Xperi Inc. Announces Participation in the BWS Financial Growth and Value Summer Investor Series

SAN JOSE, Calif.--(BUSINESS WIRE)-- Xperi Inc. (NYSE: XPER) (the “Company” or “Xperi”), an entertainment technology company that invents, develops, and delivers technologies that enable extraordinary experiences, today announced that CEO Jon Kirchner and CFO Robert Andersen will host meetings at the BWS Financial Growth and Value Summer Investor Series on August 25, 2026, at the AMA Conference Center in New York City.

If you would like to schedule a meeting with Xperi Inc., please reach out to your BWS representative or email [email protected].

About Xperi Inc.

Xperi invents, develops, and delivers technologies that enable extraordinary experiences. Xperi technologies, delivered via its brands (DTS®, HD Radio™, TiVo®) are integrated into consumer devices and media platforms worldwide, powering smart devices, connected cars and entertainment experiences, including IMAX® Enhanced, a certification and licensing program operated by IMAX Corporation and DTS, Inc. Xperi has created a unified ecosystem that reaches highly engaged consumers, driving increased value for partners, customers and consumers.

©2026 Xperi Inc. All Rights Reserved. Xperi, TiVo, DTS, HD Radio and their respective logos are trademark(s) or registered trademark(s) of Xperi Inc. or its subsidiaries in the United States and other countries. IMAX is a registered trademark of IMAX Corporation. All other trademarks and content are the property of their respective owners.

XPER – C

View source version on businesswire.com: https://www.businesswire.com/news/home/20260806573418/en/

Xperi Investor Contact:
Idalia Rodriguez
Arbor Advisory Group
+1 203-293-3325
[email protected]

Media Contact:
Tom Huntington
+1 619-743-9057
[email protected]

Source: Xperi Inc

You May Also Be Interested In

• Oscar Health Announces Thrive Capital’s Completion of Oscar Health Common Stock Distribution to its Limited Partners
• Otsuka Presents New Phase 3b Results for SIMTRIYO® (centanafadine) Highlighting Consistent Improvements Across ADHD Symptoms, Anxiety, and Associated Features in Adults with ADHD and Comorbid Anxiety
• Leading Enterprise AI and Automation Provider, Fooyo, Signs Macau Tourism MOU to Expand AI Tools for Destination Marketing